You can buy or sell LQDA and other stocks, options, ETFs, and crypto commission-free!
Liquidia Technologies, Inc. Common Stock, also called Liquidia Technologies, is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. Read More It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.
Morrisville, North Carolina
52 Week High
52 Week Low
Seeking AlphaMay 6
Liquidia Technologies Inc. (LQDA) CEO Neal Fowler on Q1 2019 Results - Earnings Call Transcript
Liquidia Technologies Inc. (NASDAQ:LQDA) Q1 2019 Earnings Conference Call May 2, 2019 8:00 AM ET Company Participants Jenny Kobin - IR Neal Fowler - CEO Tim Albury - CFO Robert Roscigno - SVP, Product Development & Program Lead for LIQ861 Conference Call Participants Stacy Ku - Cowen & Company Liana Moussatos - Wedbush Securities Serge Belanger - Needham & Company Chris Howerton - Jefferies Operator Good day, ladies and gentlemen, and welcome to the Liquidia First Quarter 2019 Financial Results ...
Expected Jul 22, Pre-Market